Lipolytic responsiveness to epinephrine in nondiabetic and diabetic humans

G. D. Divertie, Michael Dennis Jensen, P. E. Cryer, J. M. Miles

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

To determine whether the sensitivity of adipose tissue lipolysis to catecholamines is increased in poorly controlled insulin-dependent diabetes, the lipolytic response to epinephrine was measured in seven nondiabetic volunteers and seven poorly controlled diabetic subjects with use of [1- 14C]palmitate as a tracer. Subjects received sequential 1-h infusions of epinephrine, which produced epinephrine concentrations of ~1,000, ~1,750, ~3,500, and ~6,000 pmol/l. A pancreatic clamp was used to maintain constant plasma hormone levels. Concentration-response curves were constructed for each subject from the integrated lipolytic response during each epinephrine infusion. There was no difference in maximal lipolytic response (117 ± 19 vs. 152 ± 11 μmol · kg-1 · h-1) or in maximally effective (3,171 ± 267 vs. 3,357 ± 349 pmol/l) or half-maximally effective (1,081 ± 109 vs. 1,015 ± 120 pmol/l) epinephrine concentrations between nondiabetic and diabetic subjects, respectively (all P = NS). In control subjects, maximum β-hydroxybutyrate concentrations were achieved at lower epinephrine concentrations than those required for a maximum lipolytic effect. Thus, under pancreatic clamp conditions, the lipolytic response to epinephrine in nondiabetic and diabetic subjects was similar.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume272
Issue number6 35-6
StatePublished - Jun 1997

Fingerprint

Epinephrine
Clamping devices
Hydroxybutyrates
Palmitates
Lipolysis
Medical problems
Catecholamines
Adipose Tissue
Volunteers
Hormones
Insulin
Tissue
Plasmas

Keywords

  • Free fatty acids
  • Insulin-dependent diabetes mellitus
  • Kinetics
  • Lipolysis

ASJC Scopus subject areas

  • Physiology
  • Endocrinology
  • Biochemistry
  • Physiology (medical)

Cite this

Lipolytic responsiveness to epinephrine in nondiabetic and diabetic humans. / Divertie, G. D.; Jensen, Michael Dennis; Cryer, P. E.; Miles, J. M.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 272, No. 6 35-6, 06.1997.

Research output: Contribution to journalArticle

@article{c62850b19f8f4f8e8a9b26db25634b27,
title = "Lipolytic responsiveness to epinephrine in nondiabetic and diabetic humans",
abstract = "To determine whether the sensitivity of adipose tissue lipolysis to catecholamines is increased in poorly controlled insulin-dependent diabetes, the lipolytic response to epinephrine was measured in seven nondiabetic volunteers and seven poorly controlled diabetic subjects with use of [1- 14C]palmitate as a tracer. Subjects received sequential 1-h infusions of epinephrine, which produced epinephrine concentrations of ~1,000, ~1,750, ~3,500, and ~6,000 pmol/l. A pancreatic clamp was used to maintain constant plasma hormone levels. Concentration-response curves were constructed for each subject from the integrated lipolytic response during each epinephrine infusion. There was no difference in maximal lipolytic response (117 ± 19 vs. 152 ± 11 μmol · kg-1 · h-1) or in maximally effective (3,171 ± 267 vs. 3,357 ± 349 pmol/l) or half-maximally effective (1,081 ± 109 vs. 1,015 ± 120 pmol/l) epinephrine concentrations between nondiabetic and diabetic subjects, respectively (all P = NS). In control subjects, maximum β-hydroxybutyrate concentrations were achieved at lower epinephrine concentrations than those required for a maximum lipolytic effect. Thus, under pancreatic clamp conditions, the lipolytic response to epinephrine in nondiabetic and diabetic subjects was similar.",
keywords = "Free fatty acids, Insulin-dependent diabetes mellitus, Kinetics, Lipolysis",
author = "Divertie, {G. D.} and Jensen, {Michael Dennis} and Cryer, {P. E.} and Miles, {J. M.}",
year = "1997",
month = "6",
language = "English (US)",
volume = "272",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "6 35-6",

}

TY - JOUR

T1 - Lipolytic responsiveness to epinephrine in nondiabetic and diabetic humans

AU - Divertie, G. D.

AU - Jensen, Michael Dennis

AU - Cryer, P. E.

AU - Miles, J. M.

PY - 1997/6

Y1 - 1997/6

N2 - To determine whether the sensitivity of adipose tissue lipolysis to catecholamines is increased in poorly controlled insulin-dependent diabetes, the lipolytic response to epinephrine was measured in seven nondiabetic volunteers and seven poorly controlled diabetic subjects with use of [1- 14C]palmitate as a tracer. Subjects received sequential 1-h infusions of epinephrine, which produced epinephrine concentrations of ~1,000, ~1,750, ~3,500, and ~6,000 pmol/l. A pancreatic clamp was used to maintain constant plasma hormone levels. Concentration-response curves were constructed for each subject from the integrated lipolytic response during each epinephrine infusion. There was no difference in maximal lipolytic response (117 ± 19 vs. 152 ± 11 μmol · kg-1 · h-1) or in maximally effective (3,171 ± 267 vs. 3,357 ± 349 pmol/l) or half-maximally effective (1,081 ± 109 vs. 1,015 ± 120 pmol/l) epinephrine concentrations between nondiabetic and diabetic subjects, respectively (all P = NS). In control subjects, maximum β-hydroxybutyrate concentrations were achieved at lower epinephrine concentrations than those required for a maximum lipolytic effect. Thus, under pancreatic clamp conditions, the lipolytic response to epinephrine in nondiabetic and diabetic subjects was similar.

AB - To determine whether the sensitivity of adipose tissue lipolysis to catecholamines is increased in poorly controlled insulin-dependent diabetes, the lipolytic response to epinephrine was measured in seven nondiabetic volunteers and seven poorly controlled diabetic subjects with use of [1- 14C]palmitate as a tracer. Subjects received sequential 1-h infusions of epinephrine, which produced epinephrine concentrations of ~1,000, ~1,750, ~3,500, and ~6,000 pmol/l. A pancreatic clamp was used to maintain constant plasma hormone levels. Concentration-response curves were constructed for each subject from the integrated lipolytic response during each epinephrine infusion. There was no difference in maximal lipolytic response (117 ± 19 vs. 152 ± 11 μmol · kg-1 · h-1) or in maximally effective (3,171 ± 267 vs. 3,357 ± 349 pmol/l) or half-maximally effective (1,081 ± 109 vs. 1,015 ± 120 pmol/l) epinephrine concentrations between nondiabetic and diabetic subjects, respectively (all P = NS). In control subjects, maximum β-hydroxybutyrate concentrations were achieved at lower epinephrine concentrations than those required for a maximum lipolytic effect. Thus, under pancreatic clamp conditions, the lipolytic response to epinephrine in nondiabetic and diabetic subjects was similar.

KW - Free fatty acids

KW - Insulin-dependent diabetes mellitus

KW - Kinetics

KW - Lipolysis

UR - http://www.scopus.com/inward/record.url?scp=0030871283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030871283&partnerID=8YFLogxK

M3 - Article

C2 - 9227461

AN - SCOPUS:0030871283

VL - 272

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 6 35-6

ER -